OB/Gyn
<ѻý class='mpt-top_cat_title_description'>News, opinions and meeting coverage in obstetrics and gynecology.ѻý>
<ѻý>FDA Panel Puts Brakes on Anti-PARP Drugѻý>
WASHINGTON -- Approval of a PARP inhibitor for patients with advanced ovarian cancer should await results of an ongoing clinical trial that has the potential to answer questions about the drug's safety and efficacy, according to an FDA advisory committee that voted against immediate approval.
Jun 25, 2014
<ѻý>APA Meeting Highlights Mental Health Biologyѻý>
NEW YORK CITY -- The biological basis for normal and abnormal mental function is emerging as a dominant theme in psychiatry research, and the American Psychiatric Association annual meeting that starts here Saturday won't be an exception.
May 01, 2014
<ѻý>Ob/Gyns Uneasy With AHA's Take on Stroke in Pregnancyѻý>
NEW ORLEANS -- Recent guidelines from the American Heart Association on the management of stroke risk in pregnant women differ significantly from those issued by the American Congress of Obstetricians and Gynecologists, maternal-fetal medicine specialists said here.
Feb 10, 2014
<ѻý>10 Questions: Rep. Phil Gingrey, MD (R-Ga.)ѻý>
If you could change one thing about the healthcare system, what would it be? Eliminate Obamacare, says Rep. Phil Gingrey, MD (R-Ga.). That's his answer to just one of the 10 Questions the ѻý staff is asking leading clinicians, researchers, and leaders in their community to get their personal views on their chosen profession. In this series we share their uncensored responses.
Jan 03, 2014
<ѻý>Antidepressant Dressed Up for Menopauseѻý>
One drug company can now brag about a nonhormonal option for menopausal hos flashes. But Brisdelle is just an old drug dressed up in a new feminine name and packaging -- it's the antidepressant paroxetine, better known by its brand name, Paxil.
Dec 18, 2013